Consider efficacy, effectiveness, safety to prove all-around value of a drug

May 1, 2003

Mari Edlin is a frequent contributor to Managed Healthcare Executive. She is based in Sonoma, California.

FMCP model urges plans to think outside the cost silo when making formulary decisions